BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23997178)

  • 1. Active α-macroglobulin is a reservoir for urokinase after fibrinolytic therapy in rabbits with tetracycline-induced pleural injury and in human pleural fluids.
    Komissarov AA; Florova G; Azghani A; Karandashova S; Kurdowska AK; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2013 Nov; 305(10):L682-92. PubMed ID: 23997178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of intrapleural fibrinolysis by urokinase-alpha-macroglobulin complexes in tetracycline-induced pleural injury in rabbits.
    Komissarov AA; Mazar AP; Koenig K; Kurdowska AK; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2009 Oct; 297(4):L568-77. PubMed ID: 19666776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of plasminogen activator inhibitor 1 improves fibrinolytic therapy for tetracycline-induced pleural injury in rabbits.
    Florova G; Azghani A; Karandashova S; Schaefer C; Koenig K; Stewart-Evans K; Declerck PJ; Idell S; Komissarov AA
    Am J Respir Cell Mol Biol; 2015 Apr; 52(4):429-37. PubMed ID: 25140386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits.
    Florova G; Azghani AO; Karandashova S; Schaefer C; Yarovoi SV; Declerck PJ; Cines DB; Idell S; Komissarov AA
    Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L54-L68. PubMed ID: 28860148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models.
    Komissarov AA; Florova G; Azghani AO; Buchanan A; Boren J; Allen T; Rahman NM; Koenig K; Chamiso M; Karandashova S; Henry J; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L389-99. PubMed ID: 27343192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The time course of resolution of adhesions during fibrinolytic therapy in tetracycline-induced pleural injury in rabbits.
    Komissarov AA; Florova G; Azghani AO; Buchanan A; Bradley WM; Schaefer C; Koenig K; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2015 Sep; 309(6):L562-72. PubMed ID: 26163512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin-thrombomodulin inhibits prourokinase-mediated pleural mesothelial cell-dependent fibrinolysis.
    Iakhiaev AV; Nalian A; Koenig K; Idell S
    Thromb Res; 2007; 120(5):715-25. PubMed ID: 17275887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapleural adenoviral delivery of human plasminogen activator inhibitor-1 exacerbates tetracycline-induced pleural injury in rabbits.
    Karandashova S; Florova G; Azghani AO; Komissarov AA; Koenig K; Tucker TA; Allen TC; Stewart K; Tvinnereim A; Idell S
    Am J Respir Cell Mol Biol; 2013 Jan; 48(1):44-52. PubMed ID: 23002099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapleural low-molecular-weight urokinase or tissue plasminogen activator versus single-chain urokinase in tetracycline-induced pleural loculation in rabbits.
    Idell S; Azghani A; Chen S; Koenig K; Mazar A; Kodandapani L; Bdeir K; Cines D; Kulikovskaya I; Allen T
    Exp Lung Res; 2007; 33(8-9):419-40. PubMed ID: 17994370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease.
    Strange C; Baumann MH; Sahn SA; Idell S
    Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):508-15. PubMed ID: 7842213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrapleural activation, processing, efficacy, and duration of protection of single-chain urokinase in evolving tetracycline-induced pleural injury in rabbits.
    Idell S; Allen T; Chen S; Koenig K; Mazar A; Azghani A
    Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L25-32. PubMed ID: 16980376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-chain urokinase in empyema induced by Pasturella multocida.
    Idell S; Jun Na M; Liao H; Gazar AE; Drake W; Lane KB; Koenig K; Komissarov A; Tucker T; Light RW
    Exp Lung Res; 2009 Oct; 35(8):665-81. PubMed ID: 19895321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 1 trial of intrapleural LTI-01; single chain urokinase in complicated parapneumonic effusions or empyema.
    Beckert L; Brockway B; Simpson G; Southcott AM; Lee YCG; Rahman N; Light RW; Shoemaker S; Gillies J; Komissarov AA; Florova G; Ochran T; Bradley W; Ndetan H; Singh KP; Sarva K; Idell S
    JCI Insight; 2019 Apr; 5(10):. PubMed ID: 30998508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision targeting of the plasminogen activator inhibitor-1 mechanism increases efficacy of fibrinolytic therapy in empyema.
    Florova G; Girard RA; Azghani AO; Sarva K; Buchanan A; Karandashova S; DeVera CJ; Morris D; Chamiso M; Koenig K; Cines DB; Idell S; Komissarov AA
    Physiol Rep; 2021 May; 9(9):e14861. PubMed ID: 33991465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins.
    Higazi AA; Upson RH; Cohen RL; Manuppello J; Bognacki J; Henkin J; McCrae KR; Kounnas MZ; Strickland DK; Preissner KT; Lawler J; Cines DB
    Blood; 1996 Jul; 88(2):542-51. PubMed ID: 8695802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits.
    Idell S; Mazar A; Cines D; Kuo A; Parry G; Gawlak S; Juarez J; Koenig K; Azghani A; Hadden W; McLarty J; Miller E
    Am J Respir Crit Care Med; 2002 Oct; 166(7):920-6. PubMed ID: 12359647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
    Altmann ES; Crossingham I; Wilson S; Davies HR
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes.
    Nykjaer A; Petersen CM; Møller B; Jensen PH; Moestrup SK; Holtet TL; Etzerodt M; Thøgersen HC; Munch M; Andreasen PA
    J Biol Chem; 1992 Jul; 267(21):14543-6. PubMed ID: 1378833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Novel Targeted Therapy for Pleural Organization and Fibrosis.
    Tucker TA; Idell S
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of single chain urokinase binding, internalization, and degradation by a plasminogen activator inhibitor 1-derived peptide.
    Zhang L; Strickland DK; Cines DB; Higazi AA
    J Biol Chem; 1997 Oct; 272(43):27053-7. PubMed ID: 9341144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.